Rondol

NEWS

Extrusion for pharma applications: An update

Victoire de Margerie (CEO of Rondol), Pascal Boulet (Institut Jean Lamour), and Maël Gallas (Rondol) published a new article in …

A new organization for Rondol

11 months after we raised funds, proud to announce that we have achieved the next step team building we were …

Aspirin for oncology therapies

New milestone on the RONDOL SEQENS joint cooperation to improve bioavailability of selected molecules with the successful installation of our …

Rondol and Seqens Award by l’Usine Nouvelle

Happy to receive the Trophée Initiative Chimie that highlights the potential to improve bioavailability of active principles and reduce the …

1st Paper in International Journal of Pharmaceutics

Great paper in International Journal of Pharmaceutics about solutions for the pharmaceutical industry in accessing continuous manufacturing technologies and allowing …

Rondol patent for vertical extruder granted under US law

A great step on our road to adapting extrusion technology to the micro scale and to Pharma standards. And another …